Navigation Links
Labopharm Reports Results for First Quarter Fiscal 2009
Date:5/7/2009

g-term debt 18,642 20,265 ------------------------------------------------------------------------- Total liabilities 57,029 56,252 ------------------------------------------------------------------------- Shareholders' equity Share capital Common shares, no par value, unlimited authorized shares, 56,833,696 and 56,826,063 issued as at March 31, 2009 and December 31, 2008, respectively 241,983 241,967 Warrants 751 751 Contributed surplus 15,722 14,937 Deficit (255,489) (247,515) Accumulated other comprehensive income 445 1,395 ------------------------------------------------------------------------- Total shareholders' equity 3,412 11,535 ------------------------------------------------------------------------- 60,441 67,787 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Labopharm Inc. INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended: March 31, March 31, 2009 2008 (thousands of Canadian dollars, (Restated) except share and per share amounts) $ $ ------------------------------------------------------------------------- REVENUE Product sales 3,802 2,158 Licensing 1,155
'/>"/>
SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 The New York Group ... Surgery at the Icahn School of Medicine at Mount ... Group for Plastic Surgery gives residents of New York ... team of world-renowned plastic surgeons performing innovative reconstructive and ... MD, who led NYGPS, was named the Director of ...
(Date:9/22/2014)... familiar "lub-dub" pattern that speeds up or slows down ... isn,t as regular as you might think. In fact, ... at a "constant" heart rateand that variability, doctors have ... rate variability (HRV) has been found to be predictive ... failure and inflammation. For athletes, a drop in HRV ...
(Date:9/22/2014)... MEMPHIS, Tenn. (PRWEB) September 22, 2014 ... cloud contact center and customer service solutions. , ... Memphis is focused on customer care for the ... vertical landscapes continue to offer new challenges and ... dedicated to helping attendees identify best practices, network ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, ... a child,s brain processes sounds might help identify the ... Observing children,s brainwaves may also allow identification of ... reported. "The finding that the brain,s response to ... is hugely promising," said senior researcher Sophie Molholm, an ...
(Date:9/22/2014)... Medical experts this past weekend gathered ... discuss brain-related diseases facing an aging population, including ... disorders. , Each of the 50 attendees ... memory care community or hospice office. Silverado, with ... hosts the annual event to facilitate the exchange ...
Breaking Medicine News(10 mins):Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 3Health News:Variability keeps the body in balance 2Health News:Variability keeps the body in balance 3Health News:Variability keeps the body in balance 4Health News:LiveOps To Lead Panel Discussion At Customer Response Summit Memphis 2Health News:Brainwaves May Help Gauge Autism Severity: Study 2Health News:Brainwaves May Help Gauge Autism Severity: Study 3Health News:Brainwaves May Help Gauge Autism Severity: Study 4Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3
... emission tomography (PET) and computed tomography for radiation therapy ... for excellent, local and regional disease control when compared ... March 1 issue of the International Journal for Radiation ... Therapeutic Radiology and Oncology. , CT has been the ...
... of South,Carolina announced today that the second annual National ... on Wednesday, April 30, 2008., Blue Cross and ... employers, will encourage their employees to wear comfortable walking,shoes ... lunchtime walk., The motivation behind National Walk @ ...
... of Pennsylvania School of Veterinary Medicine have identified a ... the process by which viruses escape from cells and ... the first time how ISG15 slows the spread of ... how ISG15 successfully inhibits other viruses, including HIV-1 and ...
... 4 The number of Arab,Americans is growing. ... largest,concentration of people of Arab descent outside of ... so do their healthcare needs. Like many,other ethnic ... educational challenges in accessing health information and,care., ...
... security control of e-Passport system in Immigration Department of ... ... SAN JOSE, Calif., March 4 Titanium Group,Ltd. (OTC Bulletin ... contract was awarded in October 2006 to,develop Biometric Sign-on Infrastructure ...
... Offerings to Help Hospitals Prevent Infections, DUBLIN, ... of products and services that improve the safety ... agreement to,acquire the assets of privately held Enturia ... leading line of infection prevention,products sold under the ...
Cached Medicine News:Health News:PET/CT planning beneficial for head and neck cancer patients 2Health News:S.C. BlueCross Announces Second Annual National Walk @ Lunch Day 2Health News:Penn scientists find a protein that inhibits Ebola from reaching out to infect neighboring cells 2Health News:International and Domestic Leaders to Convene to Tackle Health Issues in the Arab American Community 2Health News:Titanium Group Implements Biometric Sign-On Infrastructures for Hong Kong Immigration Department 2Health News:Titanium Group Implements Biometric Sign-On Infrastructures for Hong Kong Immigration Department 3Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 2Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 3Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 4Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 5Health News:Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million 6
(Date:9/22/2014)... WASHINGTON and SHANGHAI ... Healthcare Group (BHG), a global knowledge leader in ... strategic partnership to support healthcare innovation in ... for personal connected health technologies. Continua and BHG ... Healthcare Forum being held this week in ...
(Date:9/22/2014)... , Sept. 22, 2014  Aethlon Medical, ... therapeutic devices to address infectious disease, cancer and ... Advanced Research Projects Agency (DARPA) has informed the ... to proceed with year four of a five-year ... on September 30, 2011 under DARPA,s Dialysis-Like Therapeutics ...
(Date:9/22/2014)... , Sept. 22, 2014 ... of the "Global Ablation Technologies (Radiofrequency, Ultrasound, ... 2019" report to their offering. ... the global ablation technologies market has been divided ... ultrasound, microwave, cryotherapy, hydrothermal, and hydromechanical ablation technologies. ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3
... 5, 2012  InterMune, Inc. (NASDAQ: ITMN ) ... the fourth quarter ended December 31, 2011, as well ... Esbriet therapy in Germany during 2011.   InterMune ... including new efficacy data from the RECAP extension study ...
... TUCSON, Ariz. and PROVIDENCE, R.I., Jan. 5, 2012 ... it has awarded $1.0 million to Tivorsan Pharmaceuticals ... filing of an Investigational New Drug (IND) application with ... recombinant humanized form of biglycan as a potential muscular ...
Cached Medicine Technology:InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights 2InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights 3InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights 4InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights 5InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights 6InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights 7InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights 8MDA Awards $1 Million to Tivorsan Pharmaceuticals for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment 2MDA Awards $1 Million to Tivorsan Pharmaceuticals for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment 3MDA Awards $1 Million to Tivorsan Pharmaceuticals for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment 4
... For enzyme immunoassays, designed to meet the ... and allows the user to run set ... The floating manifold on this strip washer ... at a time. Reliable, compact, and self-contained, ...
... available to handle multiple assays: ... Embla 384 Cell washer has ... optimized to avoid cell disturbance. ... and have been integrated with ...
... miniGene LW is a new plate washing system ... and 384 channel microplates with flat, V-shaped or ... 8 or 16 channel nozzle heads. Simple LCD ... An optional plate stacker is available for the ...
Space-saving counter top model,User initiated manual defrost,Standard features (see above),Internal freezing compartment,Removable half-shelf in refrigerator,Two shelves in door,UL 471 Commercial Ref...
Medicine Products: